The American pharmaceutical company Pfizer has increased its sales forecast for the corona vaccine. The company announced this at the presentation on Tuesday of the quarterly figures. Pfizer now expects annual sales of $ 26 billion (about $ 21 billion) from sales of the vaccine, whereas it was previously assumed a turnover of 15 billion dollars. Pfizer expects to deliver at least 1.6 billion doses worldwide this year, a number that could reach 2.5 billion.
The vaccine that Pfizer has developed together with the German pharmaceutical company BioNTech was the first to be approved in the United States and European Union. Pfizer and BioNTech each account for half the cost of the vaccine. They also share the gross winnings. In 2020, Pfizer had total sales, including corona vaccine sales, of $ 41.9 billion. Then about 25 to 29 percent of the proceeds consisted of profit.
Made last week the British-Swedish pharmaceutical company AstraZeneca is known sold $ 275 million ($ 227 million) worth of corona vaccines in the first quarter of this year. AstraZeneca reported to have delivered more than 300 million doses worldwide, most of them in Europe. In total, the proceeds in the first three months amounted to more than 7.3 billion dollars.
This article is also part of our live blog: Priority vaccination for 1.4 million people with a medical indication
–
